Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AInCP

Financiado

clinical validation of Artificial Intelligence for providing a personalized moto...

clinical validation of Artificial Intelligence for providing a personalized motor clinical profile assessment and rehabilitation of upper limb in children with unilateral Cerebral Palsy Unilateral Cerebral palsy (UCP) is the most common neurological chronic disease in childhood with a significant burden on children, their families and health care system. AInCP aims to develop evidence-based clinical Decision Sup... ver más

31/05/2027

UNIPI

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

UNIVERSITA DI PISA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 13 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-05-18

HORIZON-HLTH-2021-DISEASE-04-04: Clinical validation of artificial i... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 3 años

0% 100% 100%

13 Participantes

UNIPI

1.44M€ | Lider

THE UNIVERSITY OF QUEENSLAND

N.D. | Participante

NOLDUS

310.00K€ | Participante

KHYMEIA GROUP

679.95K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TED2021-131358A-I00 EJERCICIO TERAPEUTICO MEDIANTE JUEGO SERIO EN DISPOSITIVOS M... 48K€ Cerrado

PCI2023-143405 Ingeniería biomédica 194K€ Cerrado

PID2021-124515OA-I00 REHABOT: REHABOT: ASISTENTE INTELIGENTE PARA COMPLEMENTAR Y... 88K€ Cerrado

INTRECOM Intracranial Neuro Telemetry to Restore Communication 4M€ Cerrado

TEC2011-29106-C02-02 SISTEMA INTELIGENTE IWALKER: REHABILITACION COLABORATIVA 35K€ Cerrado

PHRASE Personalised Health cognitive assistance for RehAbilitation... 2M€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2022-05-18
Fecha Fin: 2027-05-31

Líder del proyecto

UNIVERSITA DI PISA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Descripción del proyecto Unilateral Cerebral palsy (UCP) is the most common neurological chronic disease in childhood with a significant burden on children, their families and health care system. AInCP aims to develop evidence-based clinical Decision Support Tools (DST) for personalized functional diagnosis, Upper Limb (UpL) assessment and home-based intervention for children with UCP, by developing, testing and validating trustworthy Artificial Intelligence (AI) and cost-effective strategies. The AInCP approach will: i) establish a clinical diagnosis and accurate prognosis for treatment response of individual UCP profiles, by employing a multimodal approach including clinical phenotyping, advanced brain imaging and real-life monitoring of UpL function, and ii) provide personalized home-based treatment, from advanced ICT and AI technologies. The AInCP will build upon personalized diagnostic and rehabilitative DST (dDST and rDST) to be developed and validated through large observational and rehabilitation studies, including at least 200 and 150 children with UCP, respectively. Using data driven and AI approach, dDST and rDST will be combined for developing a theranostic DST (tDST) that will allow the re-designing of an economical, ethical, sustainable decision-making process for delivering a personalized and validated approach, focused on the care, monitoring and rehabilitation of UpL in children with UCP. AInCP is a significant example of a transdisciplinary approach, where all project collaborators (clinicians, data scientists, physicists, engineers, economists, ethicists, SMEs, children and parent associations) will work closely together in building the AInCP approach. This approach will, therefore, hinge on transdisciplinary contributions, multi-dimensional data, sets of innovative devices and fair AI-based algorithms, clinically effective and able to reduce users? and market barriers of acceptability, reimbursability and adoption of the proposed solution.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores